Rx-to-OTC Switches Represent Huge Market Potential

Labeling / Marketing, Pharmaceutical Consulting News, Regulatory Affairs, Regulatory Updates, Research & Development, Submissions

Rx-to-OTC switches and the related repositioning of pharmaceutical products from prescription (Rx) dispensing to the retail (over-the-counter or OTC) drug space represent huge market potential. A Strong Domestic OTC Market The U.S. market for OTCs more than doubled between 2007 and 2013 growing from $16 billion to $33 billion. [1] By the beginning of 2014,…

Orphan Drugs – Opportunities and Issues

Orphan Drugs – Opportunities & Issues

Labeling / Marketing, Regulatory Affairs, Regulatory Updates, Research & Development, Submissions

Orphan Drugs Offer Revenue and Profit Upside Many have speculated that the era of the blockbuster drug has ended. Indeed, 2014 marked the 6th year of a patent cliff in which a majority of U.S. blockbusters fell to generic competition. [1] Patent cliff notwithstanding, of the 43 global blockbusters on the market in 2012, 18…